Tumor induced immunosuppression.
D000510:Alpha-Globulins / Q000032:analysis; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000276:immunology; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D010956:Plasmapheresis; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology / Q000528:radiation effects; D000509:alpha-Fetoproteins / Q000032:analysis
D000510:Alpha-Globulins; D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D007166:Immunosuppressive Agents; D000509:alpha-Fetoproteins; D003520:Cyclophosphamide